Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.32 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.32 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.32 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4079093 | 0.86 | — | — | |
| SCHEMBL4090915 | 0.80 | DNM1 (0.33) | DNM1ADRB2ADRB1ADRB3ATM | |
| SCHEMBL557068 | 0.78 | TSHR (0.36) | DNM1ADRB2ADRB1ADRB3ATM | |
| SCHEMBL7935124 | 0.72 | DNM1 (0.39) | DNM1ALDH1A1CNR1CNR2 | |
| SCHEMBL4092993 | 0.72 | ADRB2 (0.38) | DNM1ADRB2ADRB1ADRB3ATM | |
| SCHEMBL7937310 | 0.71 | DNM1 (0.42) | DNM1ALDH1A1CNR1CNR2 | |
| SCHEMBL703587 | 0.70 | ADRB2 (0.36) | DNM1ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL703595 | 0.70 | ADRB2 (0.36) | DNM1ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL4092985 | 0.70 | ADRB2 (0.36) | DNM1ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL705365 | 0.68 | ADRB2 (0.35) | DNM1ADRB2ADRB1ADRB3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1915399-B1 | RECOVERABLE POLYMER-BOUND HOMOGENEOUS CATALYSTS FOR CATALYTIC CHAIN TRANSFER PROCESSES | COATINGS FOREIGN IP CO LLC (US) | 2013-11-20 | — | — | EP | claimed |
| US-8030422-B2 | Recoverable polymer-bound homogeneous catalysts for catalytic chain transfer process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-10-04 | — | — | US | claimed |
| EP-2272885-A2 | Hydroxyl-terminated thiocarbonate containing compounds, polymers, and copolymers, and polyurethanes and urethane acrylics made therefrom | Lubrizol Advanced Materials, Inc. (US) | 2011-01-12 | — | — | EP | claimed |
| EP-1915399-A1 | RECOVERABLE POLYMER-BOUND HOMOGENEOUS CATALYSTS FOR CATALYTIC CHAIN TRANSFER PROCESSES | E.I.Du pont de nemours and company (US) | 2008-04-30 | — | — | EP | claimed |
| WO-2007024634-A1 | RECOVERABLE POLYMER-BOUND HOMOGENEOUS CATALYSTS FOR CATALYTIC CHAIN TRANSFER PROCESSES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-03-01 | — | — | WO | claimed |
| EP-0791016-A1 | POLYMER SYNTHESIS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-08-27 | — | — | EP | claimed |
| WO-1996015157-A1 | POLYMER SYNTHESIS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-05-23 | — | — | WO | claimed |
| EP-2970538-B1 | POLYMERIZATION PROCESS PROTECTION MEANS | DUPONT ELECTRONICS INC (US) | 2021-10-20 | — | — | EP | disclosed |
| CN-107428955-B | Proton binding polymers for oral administration | 特里赛达公司 | 2021-09-21 | — | — | CN | disclosed |
| US-9925214-B2 | Proton-binding polymers for oral administration | TRICIDA, INC. (US) | 2018-03-27 | — | — | US | disclosed |
| WO-2016123675-A1 | TARGETING CONSTRUCTS FOR DELIVERY OF PAYLOADS | THE UNIVERSITY OF QUEENSLAND (AU) | 2016-08-11 | — | — | WO | disclosed |
| US-20160074430-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | RENIBUS THERAPEUTICS, INC. | 2016-03-17 | — | — | US | disclosed |
| EP-2970538-A1 | POLYMERIZATION PROCESS PROTECTION MEANS | E. I. du Pont de Nemours and Company (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2007094858-A2 | PROCESS FOR AMINATION OF ACRYLIC MACROMONOMERS AND PRODUCTS THEREFROM | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-08-23 | — | — | WO | disclosed |
| US-20070161675-A1 | PROCESSES FOR HYDRAZINE ADDITION TO ACRYLIC MACROMONOMERS AND PRODUCTS THEREFROM | E. I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-07-12 | — | — | US | disclosed |
| WO-2007070724-A2 | PIGMENT DISPERSIONS CONTAINING AMINATED ACRYLIC MACROMONOMER DISPERSANT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-06-21 | — | — | WO | disclosed |
| US-20070142546-A1 | Pigment dispersions containing aminated acrylic macromonomer dispersant | AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) | 2007-06-21 | — | — | US | disclosed |
| WO-2007024634-A1 | RECOVERABLE POLYMER-BOUND HOMOGENEOUS CATALYSTS FOR CATALYTIC CHAIN TRANSFER PROCESSES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-03-01 | — | — | WO | disclosed |
| EP-1639019-A1 | PRESSURIZED HIGH TEMPERATURE POLYMERIZATION PROCESS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-03-29 | — | — | EP | disclosed |
| WO-2005003185-A1 | PRESSURIZED HIGH TEMPERATURE POLYMERIZATION PROCESS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160074430-A1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | SLC9A1, HRH2, SLC9A2 | DNM1 650/4885ADRB2 4338/4885ADRB1 4371/4885 |
| US-20070161675-A1 | PROCESSES FOR HYDRAZINE ADDITION TO ACRYLIC MACROMONOMERS AND PRODUCTS THEREFROM | HNMT, BHMT2, BHMT | DNM1 1248/4885ADRB2 3940/4885ADRB1 3802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.